EP 0833930 A2 19980408 - FUSED SOLUBLE MHC HETERODIMER:PEPTIDE COMPLEXES AND THEIR USES
Title (en)
FUSED SOLUBLE MHC HETERODIMER:PEPTIDE COMPLEXES AND THEIR USES
Title (de)
FUSIERTE LÖSLICHE MHC HETERODIMÄR:PEPTIDKOMPLEXE UND DEREN VERWENDUNGEN
Title (fr)
COMPLEXES SOLUBLES D'HETERODIMERES DE LMH FUSIONNES ET DE PEPTIDES, ET LEUR UTILISATION
Publication
Application
Priority
- US 9610102 W 19960607
- US 48000295 A 19950607
- US 48324195 A 19950607
- US 48213395 A 19950607
- US 596495 P 19951027
Abstract (en)
[origin: WO9640944A2] Immune modulators, such as soluble, fused MHC heterodimers and soluble, fused MHC heterodimer:peptide complexes, are described. Related methods and peptides are also disclosed. In a preferred aspect, these mediators and methods are related to autoimmunity.
IPC 1-7
C12N 15/62; C07K 19/00; C12N 15/85; A61K 38/17; C07K 16/28; C07K 16/18; C07K 16/40; C12N 5/08
IPC 8 full level
C12N 15/09 (2006.01); A61K 39/00 (2006.01); A61P 37/00 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); C07K 14/74 (2006.01); C07K 19/00 (2006.01); C12N 5/00 (2006.01); C12N 5/10 (2006.01); C12N 9/88 (2006.01); C12R 1/91 (2006.01)
CPC (source: EP KR)
A61K 38/17 (2013.01 - KR); A61P 37/00 (2018.01 - EP); C07K 14/4711 (2013.01 - EP); C07K 14/70539 (2013.01 - EP); C07K 19/00 (2013.01 - KR); C12N 9/88 (2013.01 - EP); C12N 15/62 (2013.01 - KR); A61K 39/00 (2013.01 - EP KR); A61K 2039/5158 (2013.01 - EP KR); C07K 2319/00 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9640944 A2 19961219; WO 9640944 A3 19970123; AU 6331696 A 19961230; CA 2224205 A1 19961219; EP 0833930 A2 19980408; JP H11507238 A 19990629; KR 19990022641 A 19990325
DOCDB simple family (application)
US 9610102 W 19960607; AU 6331696 A 19960607; CA 2224205 A 19960607; EP 96922445 A 19960607; JP 50220497 A 19960607; KR 19970709216 A 19971206